Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidehiko Okazawa

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 15, 2021
ER Imaging for Estrogen-Related Tumors Is Bothersome but UsefulHidehiko Okazawa
Annals of Nuclear Medicine|April 9, 2009
Clinical impact of hemodynamic parameter measurement for cerebrovascular disease using positron emission tomography and (15)O-labeled tracersHidehiko Okazawa, Takashi Kudo
Brain and Nerve = Shinkei Kenkyu No Shinpo|February 6, 2019
[Positron Emission Tomography Imaging for Oxidative Stress in Mitochondrial and Neurodegenerative Diseases]Masamichi Ikawa, Hidehiko Okazawa, Makoto Yoneda
ACS Omega|August 23, 2021
Utilization of Antibody Allows Rapid Clearance of Nanoparticle Probes from Blood without the Need of Probe ModificationsAkira Makino, Hidehiko Okazawa, Yasushi Kiyono
Biochimica Et Biophysica Acta. General Subjects|December 28, 2020
Molecular imaging for mitochondrial metabolism and oxidative stress in mitochondrial diseases and neurodegenerative disordersMasamichi Ikawa, Hidehiko Okazawa, Makoto Yoneda
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular diseaseHidehiko Okazawa, Hiroshi Yamauchi, Kanji Sugimoto, et al.
Antioxidants (Basel, Switzerland)|September 17, 2020
PET Imaging for Oxidative Stress in Neurodegenerative Disorders Associated with Mitochondrial DysfunctionMasamichi Ikawa, Hidehiko Okazawa, Yasunari Nakamoto, et al.
Frontiers in Psychiatry|June 25, 2019
Do Individuals With Autism Spectrum Disorders Help Other People With Autism Spectrum Disorders? An Investigation of Empathy and Helping Motivation in Adults With Autism Spectrum DisorderHidetsugu Komeda, Hirotaka Kosaka, Toru Fujioka, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 24, 2022
[The 43rd Report on the Survey of Adverse Reactions to Radiopharmaceuticals (46th Survey in 2020)], Hidehiko Okazawa, Tomoya Uehara, et al.
Clinical Nuclear Medicine|May 4, 2013
18F-fluorothymidine PET is a potential predictive imaging biomarker of the response to gemcitabine-based chemotherapeutic treatment for recurrent ovarian cancer: preliminary results in three patientsHideaki Tsuyoshi, Fumiko Morishita, Makoto Orisaka, et al.
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 15, 2021
ER Imaging for Estrogen-Related Tumors Is Bothersome but UsefulHidehiko Okazawa
Annals of Nuclear Medicine|April 9, 2009
Clinical impact of hemodynamic parameter measurement for cerebrovascular disease using positron emission tomography and (15)O-labeled tracersHidehiko Okazawa, Takashi Kudo
Brain and Nerve = Shinkei Kenkyu No Shinpo|February 6, 2019
[Positron Emission Tomography Imaging for Oxidative Stress in Mitochondrial and Neurodegenerative Diseases]Masamichi Ikawa, Hidehiko Okazawa, Makoto Yoneda
ACS Omega|August 23, 2021
Utilization of Antibody Allows Rapid Clearance of Nanoparticle Probes from Blood without the Need of Probe ModificationsAkira Makino, Hidehiko Okazawa, Yasushi Kiyono
Biochimica Et Biophysica Acta. General Subjects|December 28, 2020
Molecular imaging for mitochondrial metabolism and oxidative stress in mitochondrial diseases and neurodegenerative disordersMasamichi Ikawa, Hidehiko Okazawa, Makoto Yoneda
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular diseaseHidehiko Okazawa, Hiroshi Yamauchi, Kanji Sugimoto, et al.
Antioxidants (Basel, Switzerland)|September 17, 2020
PET Imaging for Oxidative Stress in Neurodegenerative Disorders Associated with Mitochondrial DysfunctionMasamichi Ikawa, Hidehiko Okazawa, Yasunari Nakamoto, et al.
Frontiers in Psychiatry|June 25, 2019
Do Individuals With Autism Spectrum Disorders Help Other People With Autism Spectrum Disorders? An Investigation of Empathy and Helping Motivation in Adults With Autism Spectrum DisorderHidetsugu Komeda, Hirotaka Kosaka, Toru Fujioka, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 24, 2022
[The 43rd Report on the Survey of Adverse Reactions to Radiopharmaceuticals (46th Survey in 2020)], Hidehiko Okazawa, Tomoya Uehara, et al.
Clinical Nuclear Medicine|May 4, 2013
18F-fluorothymidine PET is a potential predictive imaging biomarker of the response to gemcitabine-based chemotherapeutic treatment for recurrent ovarian cancer: preliminary results in three patientsHideaki Tsuyoshi, Fumiko Morishita, Makoto Orisaka, et al.
Pageof 26